medigraphic.com
Boletín Clínico de la Asociación Médica del Hospital Infantil del Estado de Sonora

2024, Número 1

<< Anterior Siguiente >>

Bol Clin Hosp Infant Edo Son 2024; 41 (1)


Fascitis Necrosante: conceptos actuales

Magaña TJE, Mercado DCU, Reyes GU, Reyes HKL, Vargas MME, Carreón GJM, Quero HA, López CG, de Lara HJ, Cuevas LLL, González AE, Yalaupari MJP

Idioma: Español
Referencias bibliográficas: 27
Paginas: 47-53
Archivo PDF: 276.93 Kb.


RESUMEN

La fascitis necrosante es una entidad infecciosa rápidamente progresiva que afecta las fascias subcutáneas, causando necrosis y una respuesta sistémica inflamatoria, acompañada de choque séptico o, incluso, la muerte. Existen factores de riesgo para que esto ocurra: inmunocompromiso, edad, patologías de base, etc. Es una urgencia médico-quirúrgica potencialmente mortal porque se debe retirar la fuente infecciosa por desbridamiento agresivo o amputación –si fuera necesario–, y administrar de forma inmediata antimicrobianos de amplio espectro. Todo ello se debe realizar dentro de las primeras 6 horas del ingreso al hospital, ya que así puede mejorar el pronóstico en forma importante. El presente es una revisión actualizada de esta entidad, en ella se resaltan scores de clasificación, tipos y formas de invasión de las bacterias y su abordaje oportuno.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Duane TM, Huston JM, Collom M, Beyer A, Parli S,Buckman S, et al. Surgical Infection Society 2020updated guidelines on the management of complicatedskin and soft tissue infections. Surg Infect(Larchmt). 2021; 22: 383-99.

  2. Dennis L. Stevens A, L. Bison, Henry F. ChambersE. Patchen D, Ellie JC, Goldstein SL. Practice Guidelinesfor the Diagnosis and Management of Skinand Soft Tissue Infections: 2014 Update by the InfectiousDiseases Society of America. Clinical InfectiousDiseases. 2014; 59: 27-31.

  3. Jiménez-Martínez A, Ramírez-Ponce B, Reyes-GómezU, Reyes-Hernández U, Reyes-Hernández D,Reyes-Hernández K, et al. Fascitis necrosante porestreptococo del grupo G: reporte de un caso. EnfInf Microbiol. 2013; 33(2): 85-9.

  4. Noor A, Krilov L. Necrotizing Fasciitis. PediatrRev. 2021; 42(10): 573-575. Available from: https://doi.org/10.1542/pir.2020-003871

  5. 5. Pfeifle VA, Gros SJ, Holland-Cunz S, KämpfenA. Necrotizing fasciitis in children due to minorlesions. J Pediatr Surg Case Rep. 2017; 25:52-5. Available from: https://doi.org/10.1016/j.epsc.2017.08.005.

  6. Tessier JM, Sanders J, Sartelli M, et al. Necrotizingsoft tissue infections: A focused review of pathophysiology,diagnosis, operative management,antimicrobial therapy, and pediatrics. Surg Infect(Larchmt). 2020; 21(2): 81-93.

  7. Hsiao CT, Chang CP, Huang TY, Chen YC, Fann WC.Prospective Validation of the Laboratory Risk Indicatorfor Necrotizing Fasciitis (LRINEC) Score forNecrotizing Fasciitis of the extremities. PLOS ONE.2020; 15(1): e227748. Available from: https://doi.org/10.1371/journal.pone.0227748

  8. Wu PH, Wu KH, Hsiao CT, Wu SR, Chang CP. Utilityof modified laboratory risk indicator for necrotizingfasciitis (MLRINEC) score in distinguishing necrotizingfrom non-necrotizing soft tissue infections.World J Emerg Surg. 2021; 16(1): 26.

  9. Hartoyo E, Felicia FV. A 30-Day-Old Infant with NecrotizingFasciitis of the Perineal Region Involvingthe Scrotum Due to Methicillin-Resistant Staphylococcusaureus (MRSA) and Extended-Spectrumβ-Lactamase (ESBL)-Producing Klebsiella pneumoniae:A Case Report. Am J Case Rep. 2022 Sep28; 23:e936915. doi: 10.12659/AJCR.936915 PMID:36168215 PMCID: PMC9528849

  10. Sartelli M, Malangoni MA, May AK, Viale P, Kao LS,Catena F, et al. World Society of Emergency Surgery(WSES) Guidelines for management of skinand soft tissue infections. World J Emerg Surg.2014; 9: 57.

  11. Sartelli M, Coccolini F, Kluger Y, et al. Guías clínicasglobales WSES/GAIS/WSIS/SIS-E/AAST para pacientescon infecciones de piel y tejidos blandos.World J Emerg Surg. 2022; 17: 3. Available from:https://doi.org/10.1186/s13017-022-00406-2

  12. Bruun T, Rath E, Madsen MB, Oppegaard O, NekludovM, Arnell P, et al. Infect Study Group. RiskFactors and Predictors of Mortality in StreptococcalNecrotizing Soft-tissue Infections: A MulticenterProspective Study. Clin Infect Dis. 2021 Jan 27;72(2): 293-300. doi: 10.1093/cid/ciaa027 PMID:31923305 PMCID: PMC7840107

  13. Schröder A, Gerin A, Firth GB, Hoffmann KS, GrieveA, Oetzmann VS. A systematic review of necrotisingfasciitis in children from its first description in1930 to 2018. BMC Infect Dis. 2019 Apr 11; 19(1):317. doi: 10.1186/s12879-019-3941-3 Erratum in:BMC Infect Dis. 2019 May 27; 19(1): 469. PMID:30975101 PMCID: PMC6458701

  14. Pérez SI, Martínez PM, Piqueras VC, Gutiérrez P.Fascitis necrosante: experiencia de manejo en lasúltimas dos décadas en nuestro centro. RevistaEspañola de Cirugía Ortopédica y Traumatología.2022; 66: 429-37.

  15. Putnam LR, Richards MK, Sandvall BK, Hopper RA,Waldhausen JH, Harting MT. Laboratory evaluationfor pediatric patients with suspected necrotizingsoft tissue infections: A case-control study.J Pediatr Surg. 2016; 51(6): 1022-5. doi: 10.1016/j.jpedsurg.2016.02.076 Pub 2016 Mar 23. PMID:27233372

  16. Dauger S, Blondé R, Brissaud O. Necrotizingsoft-tissue infections in pediatric intensive care:a prospective multicenter case-series study. CritCare. 2021; 25: 139. Available from: https://doi.org/10.1186/s13054-021-03562-0

  17. Singh DK, Kapoor R, Yadav PS, Saxena S, AgarwalK, Solanki RS, et al. Morbidity and Mortality of NecrotizingFasciitis and Their Prognostic Factorsin Children. J Indian Assoc Pediatric Surg. 2022;27(5): 577-84. doi: 10.4103/jiaps.jiaps_222_21Epub 2022 Sep 9. PMID: 36530832 PMCID:PMC9757794

  18. Tom J, Liu a, Hao-Chih Tai b, Kuo-Liong Chien c, Nai-Chen Cheng. Predisposingfactors of necrotizing fasciitis with comparison tocellulitis in Taiwan: A nationwide population-basedcase–control study. Journal of the Formosan MedicalAssociation. 2020; 119(1): 118-25.

  19. Zaid Al-Qurayshi, Ronald L. Nichols, Mary T. Killackey,Emad Kandil. Mortality Risk in NecrotizingFasciitis: National Prevalence, Trend, and Burden.Surgical Infections. 2020 Dec; 840-52. Availablefrom: http://doi.org/10.1089/sur.2019.277

  20. Antibiotic Writing Group. Therapeutic Guidelines- Antibiotic. West Melbourne: Therapeutic GuidelinesLtd; 2020. Available from: http://online.tg.org.au.pklibresources.health.wa.gov.au/ip/

  21. Bratzler DW, Dellinger EP, Olsen KM, Perl TM,Auwaerter PG, Bolon MK, et al. Clinical practiceguidelines for antimicrobial prophylaxis in surgery.Am J Health Syst Pharm. 2013; 70(3): 195-283.

  22. Hedetoft M, Bennett M, Hyldegaard O. Adjuntivehyperbaric oxygen treatment for necrotizingsoft-tissue infections: A systematic review and meta-analysis. Diving and Hyperbaric Medicine, 2021;5(1): 34-44.

  23. Alexander AH, Samuel LP, Deke MB, Michael A,Benvenuti TA, Benvenuti SR, et al. Current ConceptsReview Necrotizing Fasciitis: PillagingtheAcute Phase Response. Journal Bone and JointSurgery, 2020; 18;102(6): 526-37.

  24. Lemaréchal A, Zundel S, Szavay P. Pediatric necrotizingfasciitis: Restitutio ad integrum after earlydiagnosis and aggressive surgical treatment. EurJ Pediatr Surg Rep. 2016; 4: 34-6. Available from:https://doi.org/10.1055/s-0036-1594307

  25. Horn DL, Roberts EA, Shen J, Chan JD, Bulger EM,Weiss NS, et al. Outcomes of β-Hemolytic StreptococcalNecrotizing Skin and Soft-tissue Infectionsand the Impact of Clindamycin Resistance.Clin Infect Dis. 2021 Dec 6; 73(11): e4592-e4598.doi: 10.1093/cid/ciaa976 PMID: 33151283 PMCID:PMC8664434

  26. Tuta-Quintero E, Rueda-Rodríguez A, Mantilla-Florez Y. Infecciones necrosantes de tejidos blandos.¿Cómo identificarlas, clasificarlas y tratarlas? MedicinaInterna de México. 2022; 38(3): 595-605.

  27. Wu KH, Wu PH, Chang CY, Kuo YT, Hsiao KY, HsiaoCT, et al. Diferentiating necrotizing soft tissue infectionsfrom cellulitis by soft tissue infectious fuidanalysis: a pilot study. World Journal of EmergencySurgery. (2022) 17: 1. Available from: https://doi.org/10.1186/s13017-022-00404-4




2020     |     www.medigraphic.com